Clinical Trial Update: POC-MD MRI-based Trial in Relapsing-remitting Multiple Scler [Phase 2]

View source ↗

Summary

Phase 2 MRI-based trial for relapsing-remitting multiple sclerosis has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Relapsing-remitting Multiple Sclerosis, RRMS | Phase 2 | Status: COMPLETED | Results posted: 2015-02-27